EQS-News: Instinct Bio Technical Company Holdings Inc.: Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal 2026

Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) reported a 4.7% revenue increase to USD 1.14 million in 1H FY2026, with a 9.8% rise in yen terms. The company returned to profit, posting USD 90,251 in profit after tax, compared to a loss in the prior year. Gross margin decreased to 72.6% from 79.7%, while administrative expenses fell 30.1%. The company's largest customer's share of revenue dropped to 34.8% from 51.7%.

Original reporting
Published Oct 16, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 1:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BIOT
Neutral
medium confidence
Mentioned
$BIOT
Relevance
6/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$BIOTNeutralMed
01

Why it matters

The earnings release provides the first quantitative insight into the company's post‑listing performance, setting a baseline for future guidance.

02

Market read

The release is a primary earnings disclosure for a newly listed micro‑cap, offering limited but actionable insight for niche investors.

03

What to watch

The upcoming overseas initiatives slated for 2027 could unlock future revenue streams not reflected in current numbers.

Relevance 6/10Novelty 7/10Timing: after-hours release on Oct 16, 2026

Background

Instinct Bio recently completed its Nasdaq listing in July 2026 and is now providing its first interim financial disclosure.

Company-level read

Ticker impact

$BIOTNeutralMedium confidence
Context

Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) released its unaudited 1H FY2026 results, showing a return to profit and ~10% revenue growth in yen terms.

Expected impact

potential modest upside as the market prices in the profit return, tempered by cash constraints and margin pressure

Evidence & confidence

First‑time earnings disclosure for a micro‑cap; profit surprise may attract short‑term buying, but limited scale and cash position limit upside.

Market effects

Highlights growth potential in Japan's regenerative‑medicine cosmetics niche, but limited impact on broader biotech sector.

May draw modest interest from Japan‑focused investors; unlikely to affect wider Asian markets.

Low global relevance due to small market cap and limited liquidity.

Counterpoint

Despite profit, the declining gross margin and minimal cash suggest the stock could face pressure if operating cash burn resumes.

Key entities

  • Instinct Bio Technical Company Holdings Inc.

    Japan‑based developer of stem‑cell‑based cosmetics, listed on Nasdaq under BIOT.

  • Tomoki Nagano

    Chairman and CEO of Instinct Bio, provided commentary on results.

Related articles

$BIOTMed

Instinct Bio Stock Slides After Hours: Here's What is Going on With BIOT - Instinct Bio Technical Co (NAS

Instinct Bio (BIOT) shares fell 51.46% to $1.33 Tuesday and dropped another 20.30% in after-hours to $1.06. The Nasdaq-listed biotech completed a business combination with Relativity Acquisition Corp. It entered an indicative term sheet for an equity purchase facility to sell up to $150M of common stock over three years, priced near VWAP less a discount, to fund development and working capital.

$ROSTMedAI 8/10

Ross Stores draws more bargain hunters, but higher fuel costs and softer holiday forecast weigh on stock

Ross Stores reported Q3 sales of $6.26B, up 12% YoY, with same-store sales up 8%. Net income rose to $606M ($1.91 per share), beating targets. Shares fell 2.92% as higher fuel costs and a softer holiday forecast weighed on investors. The company maintained its holiday sales growth forecast at 4-5%, down from Q3 and last year's 9%. Ross raised its full-year profit outlook to $8.75-$8.84 per share and opened 51 new stores in Q3, totaling 2,377 stores.

$HDMedAI 8/10

Home Depot Just Delivered Great News to Investors

Home Depot (HD) reported its strongest same-store sales growth since Q3 2022, with 2.2% global and U.S. growth. CFO Richard McPhail becomes CEO, while Ted Decker transitions to chairman. Revenue rose 4.9% to $43.4B, and adjusted EPS increased 3% to $3.86. The company updated its full-year guidance, expecting 4.5% sales growth and 2% EPS increase. Management highlighted strength in professional and high-ticket sales.